Institutional investors purchased a net $1.4 million shares of PCYC during the quarter ended December 2013. This may signal that the smart money is gaining interest in this company as the 66.81% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
S.A.C. CAPITAL ADVISORS LP Bought 537.9 Thousand shares of Pharmacyclics Inc
FRED ALGER MANAGEMENT, INC. Bought 486.0 Thousand shares of Pharmacyclics Inc
FIRST TRUST ADVISORS LP Bought 404.0 Thousand shares of Pharmacyclics Inc